Epatite giganto cellulare post-infantile. Risposta clinica ed istologica alla terapia immunosoppressiva

Translated title of the contribution: Post-infantile giant cell hepatitis and immunosuppressive therapy. Clinical and histological improvement after immunosuppressive therapy
  • Sergio Pittau
  • , Stefania Morelli
  • , Elisabetta Venturini
  • , Renzo Boldorini
  • , Massimo Sartori

Research output: Contribution to journalArticlepeer-review

Abstract

Giant cell transformation of hepatocytes combined with variable degrees of hepatocyte necrosis and liver fibrosis is distinctly uncommon in adults. In this age group it has most often been associated with autoimmunity, drug reaction and viral infection. Prognosis is considered quite severe ranging from mild fibrosis to established cirrhosis. We report a case of giant cell hepatitis that occurred in a 30 yrs old man, who had been taking ticlopidine for 3 years. The causative role of the drug is uncertain because aminotransferase did not fall after withdrawal. The patient fulfilled most of the criteria for a diagnosis of autoimmune hepatitis and was treated accordingly with prednisolone and azathioprine. Immunosuppressive therapy led to a clinical, biochemical and histological response.

Translated title of the contributionPost-infantile giant cell hepatitis and immunosuppressive therapy. Clinical and histological improvement after immunosuppressive therapy
Original languageItalian
Pages (from-to)126-129
Number of pages4
JournalRecenti Progressi in Medicina
Volume89
Issue number3
Publication statusPublished - Mar 1998
Externally publishedYes

Fingerprint

Dive into the research topics of 'Post-infantile giant cell hepatitis and immunosuppressive therapy. Clinical and histological improvement after immunosuppressive therapy'. Together they form a unique fingerprint.

Cite this